Directionality of HLA-DP permissive mismatches improves risk prediction in HCT for acute leukemia and MDS. Arrieta-Bolanos E, van der Burg LLJ, Gedde-Dahl T, Robin M, et al. Blood 2024 Aug 5:blood.2024024351. doi: 10.1182/blood.2024024351.

Read + Share

Amedeo Smart

Independent Medical Education

Arrieta-Bolanos E, van der Burg LLJ, Gedde-Dahl T, Robin M, et al. Directionality of HLA-DP permissive mismatches improves risk prediction in HCT for acute leukemia and MDS. Blood 2024 Aug 5:blood.2024024351. doi: 10.1182/blood.2024024351.
PMID: 39102621